54016-70-5 Usage
Description
3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide is an organic compound with the chemical formula C8H14BrNO2S. It is a brown solid and belongs to the class of thiazolium salts. 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide is characterized by its unique structure, which includes a thiazolium ring with an ethyl group at the 3rd position, a hydroxyethyl group at the 5th position, and a methyl group at the 4th position. The presence of a bromine atom in the compound provides it with specific chemical properties that make it suitable for various applications.
Uses
Used in Chemical Synthesis:
3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide is used as a catalyst in the novel synthesis of benzoin, a significant organic compound with various applications in the pharmaceutical, chemical, and materials science industries. The thiazolium salt acts as a catalyst to facilitate the condensation of benzaldehyde, leading to the formation of benzoin. The use of this thiazolium salt as a catalyst offers advantages such as improved reaction rates, selectivity, and reduced environmental impact compared to traditional catalysts.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide may be utilized as a building block or intermediate for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs with potential therapeutic applications.
Used in Material Science:
3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide can also be employed in the field of material science, particularly in the development of novel materials with specific properties. 3-Ethyl-5-(2-hydroxyethyl)-4-methylthiazolium bromide's chemical structure and reactivity can be exploited to create new materials with applications in areas such as electronics, sensors, and energy storage.
Check Digit Verification of cas no
The CAS Registry Mumber 54016-70-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,0,1 and 6 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 54016-70:
(7*5)+(6*4)+(5*0)+(4*1)+(3*6)+(2*7)+(1*0)=95
95 % 10 = 5
So 54016-70-5 is a valid CAS Registry Number.
54016-70-5Relevant articles and documents
Acetoin synthesis method
-
Paragraph 0023; 0027; 0031, (2017/10/09)
The invention provides an acetoin synthesis method. The method comprises 1, catalyst preparation: mixing 4-methyl-5-beta-hydroxyethyl thiazole (I) and bromoethane according to a mole ratio of 1: 1, carrying out heating reflux in an acetoin solvent in an oil bath for a reaction, then carrying out stirring cooling to the room temperature, carrying out rotary evaporation, recovering the solvent, standing the white precipitates, carrying out suction filtration and washing, carrying out acetoin recrystallization and carrying out drying to obtain a catalyst 3-ethyl-4-methyl-5-hydroxyethyl thiazole bromide (II) and 2, carrying out acetaldehyde condensation to obtain acetoin, adding the catalyst 3-ethyl-4-methyl-5-hydroxyethyl thiazole bromide (II) into an acetaldehyde solution, adjusting pH to 9-10, carrying out heating stirring for a condensation reaction in a pressure reactor until the pressure in the pressure reactor is 0 MPa, mixing the reaction solution, the recovered solvent and solutions collected in standing, suction filtration and washing processes, and carrying out reduced pressure distillation to obtain acetoin (III).
Methods of Treating or Preventing Cardiac Disease Associated With a High Fat Diet
-
, (2009/04/24)
The present invention relates to a method of treating or preventing cardiac disorders, myocardial inflammation or myocardial oxidative stress associated with a high fat diet or in a patient subjected to a high fat diet using the thiazolium compounds and compositions of the invention. The present invention also relates to a method of ameliorating weight gain, myocardial AGE accumulation associated, mitochondrial superoxide production, RAGE expression or PPARα expression with a high fat diet or in a patient subjected to a high fat diet using the thiazolium compounds and compositions of the invention.
Method for treating fibrotic diseases or other indications IC
-
, (2011/07/06)
Provided, among other things, is a method of treating or ameliorating or preventing an indication of the invention in an animal, including a human comprising administering an effective amount of a compound of the formula I:
